NRX Pharmaceuticals, Inc. Amortization of Debt Discount (Premium)
NRX Pharmaceuticals, Inc. (NRXP) reported Amortization of Debt Discount (Premium) of $17.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfDebtDiscountPremium · last filed 2022-08-12
- NRX Pharmaceuticals, Inc. amortization of debt discount (premium) for the quarter ending 2020-12-31 was $525.00.
- NRX Pharmaceuticals, Inc. amortization of debt discount (premium) for the quarter ending 2020-09-30 was $21.00.
- NRX Pharmaceuticals, Inc. amortization of debt discount (premium) for fiscal 2020 was $17.00K.
| Period end | Amortization of Debt Discount (Premium) 3 month | Amortization of Debt Discount (Premium) 6 month | Amortization of Debt Discount (Premium) 9 month | Amortization of Debt Discount (Premium) 12 month |
|---|---|---|---|---|
| 2020-12-31 | $525.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-03-31 | $546.00 derived: sum of 2 quarters · filed 2022-08-12 | $17.00K 10-K · filed 2022-03-31 | |
| 2020-09-30 | $21.00 derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2022-08-12 | $16.48K 10-Q/A · filed 2022-08-12 | ||
| 2020-06-30 | $16.45K 10-Q/A · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |